KALA BIO Inc
KALA7.486USD
-0.014-0.19%
交易中 （美东）报价延迟15分钟
48.30M总市值
亏损市盈率 TTM
关于 KALA BIO Inc 公司
KALA BIO, Inc. 是一家临床阶段的生物制药公司。该公司从事罕见和严重眼部疾病疗法的研究、开发和商业化。该公司基于生物制剂的试验疗法利用其专有的间充质干细胞分泌组 (MSC-S) 平台。该公司的候选产品 KPI-012 是一种人类 MSC-S，它含有多种人类衍生的生物因子，例如生长因子、蛋白酶抑制剂、基质蛋白和神经营养因子，可以潜在地纠正角膜愈合受损，这是多种严重眼部疾病的潜在病因。其 KPI-012 用于治疗持续性角膜上皮缺损 (PCED)，这是一种罕见的角膜愈合受损疾病。该公司还致力于开发 KPI-012 用于治疗角膜缘干细胞缺乏症和其他罕见角膜疾病。
公司简介
公司代码KALA
公司名称KALA BIO Inc
上市日期Jul 20, 2017
CEOMr. Todd M. Bazemore
员工数量38
证券类型Ordinary Share
年结日Jul 20
公司地址1167 Massachusetts Avenue
城市ARLINGTON
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编02476
电话17819965252
网址https://www.kalarx.com/
公司代码KALA
上市日期Jul 20, 2017
CEOMr. Todd M. Bazemore
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Darius Kharabi
Mr. Darius Kharabi
Chief Business Officer
Chief Business Officer
62.57K
-7.73%
Mr. Todd M. Bazemore
Mr. Todd M. Bazemore
President, Interim Chief Executive Officer, Chief Operating Officer
President, Interim Chief Executive Officer, Chief Operating Officer
22.77K
-15.13%
Mr. Andrew Ian Koven
Mr. Andrew Ian Koven
Lead Independent Director
Lead Independent Director
3.05K
--
Mr. Howard B. (Howie) Rosen
Mr. Howard B. (Howie) Rosen
Independent Director
Independent Director
2.71K
+935.11%
Dr. Marjan Farid, M.D.
Dr. Marjan Farid, M.D.
Independent Director
Independent Director
2.45K
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Independent Director
Independent Director
2.45K
--
Ms. Mary Reumuth
Ms. Mary Reumuth
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
--
--
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Chairman of the Board
Chairman of the Board
--
--
Dr. Kim Brazzell, Ph.D.
Dr. Kim Brazzell, Ph.D.
Head of Research and Development, Chief Medical Officer
Head of Research and Development, Chief Medical Officer
--
--
Mr. C. Daniel Myers
Mr. C. Daniel Myers
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Darius Kharabi
Mr. Darius Kharabi
Chief Business Officer
Chief Business Officer
62.57K
-7.73%
Mr. Todd M. Bazemore
Mr. Todd M. Bazemore
President, Interim Chief Executive Officer, Chief Operating Officer
President, Interim Chief Executive Officer, Chief Operating Officer
22.77K
-15.13%
Mr. Andrew Ian Koven
Mr. Andrew Ian Koven
Lead Independent Director
Lead Independent Director
3.05K
--
Mr. Howard B. (Howie) Rosen
Mr. Howard B. (Howie) Rosen
Independent Director
Independent Director
2.71K
+935.11%
Dr. Marjan Farid, M.D.
Dr. Marjan Farid, M.D.
Independent Director
Independent Director
2.45K
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Independent Director
Independent Director
2.45K
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Baker Bros. Advisors LP
18.63%
Cormorant Asset Management, LP
9.35%
SR One Capital Management, LP
9.28%
Adar1 Capital Management LLC
4.63%
Perceptive Advisors LLC
4.30%
Other
53.81%
持股股东
持股股东
占比
Baker Bros. Advisors LP
18.63%
Cormorant Asset Management, LP
9.35%
SR One Capital Management, LP
9.28%
Adar1 Capital Management LLC
4.63%
Perceptive Advisors LLC
4.30%
Other
53.81%
股东类型
持股股东
占比
Hedge Fund
43.08%
Venture Capital
9.28%
Private Equity
7.65%
Individual Investor
3.44%
Investment Advisor
2.78%
Investment Advisor/Hedge Fund
2.43%
Research Firm
0.02%
Other
31.32%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
83
4.43M
68.68%
+337.01K
2025Q1
87
4.55M
70.65%
+406.89K
2024Q4
88
3.89M
64.57%
+719.01K
2024Q3
107
2.55M
53.72%
-568.60K
2024Q2
124
2.52M
53.27%
+878.66K
2024Q1
153
1.32M
46.57%
-352.41K
2023Q4
174
1.22M
46.23%
-240.85K
2023Q3
220
1.43M
56.63%
+307.93K
2023Q2
244
1.30M
52.70%
+147.16K
2023Q1
256
646.20K
33.12%
-414.92K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Baker Bros. Advisors LP
1.20M
18.63%
--
--
Mar 31, 2025
Cormorant Asset Management, LP
603.03K
9.35%
--
--
Mar 31, 2025
SR One Capital Management, LP
598.94K
9.28%
--
--
Mar 31, 2025
Adar1 Capital Management LLC
298.95K
4.63%
+78.58K
+35.66%
Mar 31, 2025
Perceptive Advisors LLC
277.61K
4.3%
+277.61K
--
Mar 31, 2025
Woodline Partners LP
258.77K
4.01%
+258.77K
--
Mar 31, 2025
SilverArc Capital Management, LLC
246.08K
3.81%
+15.01K
+6.50%
Mar 31, 2025
AIGH Capital Management, LLC.
147.73K
2.29%
+57.26K
+63.29%
Mar 31, 2025
UBS O'Connor LLC
170.92K
2.65%
-8.02K
-4.48%
Mar 31, 2025
The Vanguard Group, Inc.
152.78K
2.37%
+99.20K
+185.19%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
公告日期
类型
比率
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
